RAGE and AGEs in Mild Cognitive Impairment of Diabetic Patients: A Cross-Sectional Study

C-Reactive Protein, Advanced Glycation End Products, and Their Receptor in Type 2 Diabetic, Elderly Patients with Mild Cognitive Impairment

(2015) Malgorzata Gorska-Ciebiada et al.   Frontiers in Aging Neuroscience

Using Serum Advanced Glycation End Products-Peptides to Improve the Efficacy of World Health Organization Fasting Plasma Glucose Criterion in Screening for Diabetes in High-Risk Chinese Subjects

(2015) Zilin Sun et al.   PLoS One

Diabetes Mellitus and the Risk of Alzheimer’s Disease: A Nationwide Population-Based Study

(2014) Chin-Chou Huang et al.   PLoS One

The Relationship Between Diabetic Retinopathy and Cognitive Impairment

(2013) R. R. Crosby-Nwaobi et al.   DIABETES CARE

Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer's Disease or Vascular Dementia

(2013) Carlo Cervellati et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Vascular risk factors in Alzheimer's disease — Preliminary report

(2012) E. Stefanova et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Serum Level of Endogenous Secretory Receptor for Advanced Glycation End Products and Other Factors in Type 2 Diabetic Patients With Mild Cognitive Impairment

(2011) G. Chen et al.   DIABETES CARE

The Feasibility of Detecting Neuropsychologic and Neuroanatomic Effects of Type 1 Diabetes in Young Children

(2011) T. Aye et al.   DIABETES CARE

Association of the RAGE G82S polymorphism with Alzheimer’s disease

(2010) Jonny Daborg et al.   JOURNAL OF NEURAL TRANSMISSION

Hardy-Weinberg Equilibrium Testing of Biological Ascertainment for Mendelian Randomization Studies

(2009) Santiago Rodriguez et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Association between the RAGE G82S polymorphism and Alzheimer’s disease

(2009) Keshen Li et al.   JOURNAL OF NEURAL TRANSMISSION

Possible Involvement of Advanced Glycation End-Products (AGEs) in the Pathogenesis of Alzheimers Disease

(2008) Masayoshi Takeuchi et al.   CURRENT PHARMACEUTICAL DESIGN

A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)

(2008) Angela Raucci et al.   FASEB JOURNAL

Decreased plasma levels of soluble receptor for advanced glycation end products in mild cognitive impairment

(2008) R. Ghidoni et al.   JOURNAL OF NEURAL TRANSMISSION

Identification, classification, and expression of RAGE gene splice variants

(2007) Barry I. Hudson et al.   FASEB JOURNAL